PDS Biotechnology Corp
PDSB· Nasdaq
PDS Biotechnology Corp
- Last sale
- Oct 2, 2026 · +6.47%
- Market cap
- $41.91M
- 55.97M shares
- Filings
- 785
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $19,025,832 | reported | |
| FY 2024 | 2024-12-31 | $22,565,524 | reported | |
| FY 2023 | 2023-12-31 | $27,762,784 | reported | |
| FY 2022 | 2022-12-31 | $29,431,027 | reported | |
| FY 2021 | 2021-12-31 | $11,254,538 | reported | |
| FY 2020 | 2020-12-31 | $7,924,450 | reported | |
| FY 2019 | 2019-12-31 | $6,099,580 | reported | |
| FY 2018 | 2018-12-31 | $830,744 revised | reported | |
| FY 2017 | 2017-12-31 | $34,311,650 | reported | |
| FY 2016 | 2016-12-31 | $24,825,379 | reported | |
| FY 2015 | 2015-12-31 | $17,839,951 | reported | |
| FY 2014 | 2014-12-31 | $8,473,522 | reported |
PDS Biotechnology Corp · CIK 1472091 · Engraved from SEC EDGAR
